Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
2(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
17%
Ph not_applicable
4
22%
Ph early_phase_1
1
6%
Ph phase_3
4
22%
Ph phase_4
5
28%
Ph phase_2
1
6%

Phase Distribution

4

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
3(16.7%)
Phase 2Efficacy & side effects
1(5.6%)
Phase 3Large-scale testing
4(22.2%)
Phase 4Post-market surveillance
5(27.8%)
N/ANon-phased studies
4(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(2)
Completed(13)
Other(3)

Detailed Status

Completed13
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.6%)
Phase 13 (16.7%)
Phase 21 (5.6%)
Phase 34 (22.2%)
Phase 45 (27.8%)
N/A4 (22.2%)

Trials by Status

recruiting211%
completed1372%
unknown317%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT06396078Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Recruiting
NCT06294600Phase 3

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

Recruiting
NCT06751121Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

Completed
NCT03130452Phase 4

Helicobacter Pylori Eradication Study

Completed
NCT05991401Phase 1

Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

Completed
NCT04724044Phase 3

Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

Completed
NCT04697641Not Applicable

Helicobacter Pylori Eradication in Functional Dyspepsia

Completed
NCT04107194Phase 3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Unknown
NCT04622891Not Applicable

Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection

Completed
NCT04525664Early Phase 1

Assessment and Management of Chronic Dyspepsia in Eastern Uganda

Completed
NCT04132479Phase 4

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

Completed
NCT04090021Phase 4

Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

Unknown
NCT03829150Not Applicable

Dexlansoprazole MR-Based Concomitant Quadruple Therapy

Completed
NCT03134378Phase 4

10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

Unknown
NCT03132714Phase 2

Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis

Completed
NCT02998437Phase 1

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

Completed
NCT02052336Phase 1

Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects

Completed
NCT00774644Not Applicable

Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18